Results 61 to 70 of about 43,490 (164)

Inhibitors of mutant isocitrate dehydrogenase for isocitrate dehydrogenase-mutant gliomas: A new standard of care?

Glioma
Emilie Le Rhun, Zhong-ping Chen, Michael Weller   +2 more
doaj   +1 more source

Isocitrate Dehydrogenase Mutations in Cancer: From Bench to Bedside Applications. [PDF]

MedComm (2020)
Fang Y, Wang X, Luo K, Dakal TC, Bai H, Xu C, Zhang G.   +6 more
europepmc   +1 more source

A novel isocitrate dehydrogenase 1 G131D mutation in glioblastoma

Chinese Medical Journal, 2021
Lei-Ming Wang, Chao Song, Ying-Xue Li, Xue-Dong Zhang, Yu-Hang Ji, Wen-Juan Wen, Peng Lyu   +6 more
doaj   +1 more source

Clinical advancement in the management of mutant isocitrate dehydrogenase (<i>IDH</i>) cancers. [PDF]

EJC Suppl
Bridgewater J, Tabatabai G, Macarulla T, Stacchiotti S.   +3 more
europepmc   +1 more source

Right Frontal Isocitrate Dehydrogenase (IDH)-Mutant WHO Grade 3 Oligodendroglioma Presenting With Morning Headache and Gait Imbalance. [PDF]

Cureus
Metwaly L.
europepmc   +1 more source

Delta-like ligand 3 expression in isocitrate dehydrogenase-mutant and isocitrate dehydrogenase-wildtype glioma is largely retained at recurrence, supporting its potential as a therapeutic target. [PDF]

Neurooncol Adv
Luning R, Maas SLN, French PJ, Hoogstrate Y, van Hijfte L, Head R, de Heer I, van den Bosch TPP, Woehrer A, van den Bent MJ, Geurts M.   +10 more
europepmc   +1 more source

Vigor tests for evaluation of crambe (Crambe abyssinica Hochst) seed quality

Journal of Seed Science
The aim of this study was adapting the methodology of the accelerated aging test (AA) and electrical conductivity test (EC) to evaluate seed quality of crambe, as well as verifying enzymatic activity in relation to vigor differences. Crambe seed lots, cv.
Sara Michelly Cruz, Marcela Carlota Nery, Adriana de Souza Rocha, Édila Vilela de Resende Von Pinho, Paulo César de Resende Andrade, Denise Cunha Fernandes dos Santos Dias   +5 more
doaj  

Predicting isocitrate dehydrogenase mutation status in acute myeloid leukemia from gene expression profiles by machine learning. [PDF]

NAR Genom Bioinform
Jung I, Vitte AL, Chuffart F, Chevalier S, Mossuz P, Khochbin S, Bourova-Flin E.   +6 more
europepmc   +1 more source

A narrative review of mutant isocitrate dehydrogenase AML in Japan based on experience with ivosidenib in AGILE. [PDF]

Int J Hematol
Hiramatsu Y, Urata S, Ishikawa T, Yamauchi T.   +3 more
europepmc   +1 more source

Mutant Isocitrate Dehydrogenase 1 Sensitizes Intrahepatic Cholangiocarcinoma Cells to MDM2 Inhibitors. [PDF]

Cancer Res Commun
Liu CT, Su YY, Chiang NJ, Li CF, Ma YC, Chang KC, Hung YH, Hung WC, Chen LT.   +8 more
europepmc   +1 more source